Arcutis Biotherapeutics ARQT Stock
Arcutis Biotherapeutics Price Chart
Arcutis Biotherapeutics ARQT Financial and Trading Overview
| Arcutis Biotherapeutics stock price | 24.44 USD |
| Previous Close | 23.51 USD |
| Open | 23.63 USD |
| Bid | 18.08 USD x 200 |
| Ask | 30.86 USD x 200 |
| Day's Range | 23.63 - 26.39 USD |
| 52 Week Range | 16.57 - 31.77 USD |
| Volume | 5.16M USD |
| Avg. Volume | 1.78M USD |
| Market Cap | 3.29B USD |
| Beta (5Y Monthly) | 1.503 |
| PE Ratio (TTM) | 118.81818 |
| EPS (TTM) | 0.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.88 USD |
ARQT Valuation Measures
| Enterprise Value | 3.16B USD |
| Trailing P/E | 118.81818 |
| Forward P/E | 19.220587 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.081298 |
| Price/Book (mrq) | 14.886104 |
| Enterprise Value/Revenue | 6.813 |
| Enterprise Value/EBITDA | 86.6 |
Trading Information
Arcutis Biotherapeutics Stock Price History
| Beta (5Y Monthly) | 1.503 |
| 52-Week Change | 32.74% |
| S&P500 52-Week Change | 13.86% |
| 52 Week High | 31.77 USD |
| 52 Week Low | 16.57 USD |
| 50-Day Moving Average | 26.08 USD |
| 200-Day Moving Average | 25.45 USD |
ARQT Share Statistics
| Avg. Volume (3 month) | 1.78M USD |
| Avg. Daily Volume (10-Days) | 2.2M USD |
| Shares Outstanding | 125.69M |
| Float | 93.81M |
| Short Ratio | 9.13 |
| % Held by Insiders | 1.77% |
| % Held by Institutions | 108.46% |
| Shares Short | 16.56M |
| Short % of Float | 14.05% |
| Short % of Shares Outstanding | 13.17% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 6.14% |
| Operating Margin (ttm) | 12.65% |
| Gross Margin | 91.14% |
| EBITDA Margin | 7.86% |
Management Effectiveness
| Return on Assets (ttm) | 5.09% |
| Return on Equity (ttm) | 15.86% |
Income Statement
| Revenue (ttm) | 463.98M USD |
| Revenue Per Share (ttm) | 3.6 USD |
| Quarterly Revenue Growth (yoy) | 59.29% |
| Gross Profit (ttm) | 422.88M USD |
| EBITDA | 36.5M USD |
| Net Income Avi to Common (ttm) | 28.52M USD |
| Diluted EPS (ttm) | 0.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 238.55M USD |
| Total Cash Per Share (mrq) | 1.9 USD |
| Total Debt (mrq) | 114.14M USD |
| Total Debt/Equity (mrq) | 51.74 USD |
| Current Ratio (mrq) | 2.917 |
| Book Value Per Share (mrq) | 1.756 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 39.31M USD |
| Levered Free Cash Flow (ttm) | 21.69M USD |
Profile of Arcutis Biotherapeutics
| Country | United States |
| State | CA |
| City | Westlake Village |
| Address | 3027 Townsgate Road |
| ZIP | 91361 |
| Phone | 805 418 5006 |
| Website | https://www.arcutis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 354 |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Q&A For Arcutis Biotherapeutics Stock
What is a current ARQT stock price?
Arcutis Biotherapeutics ARQT stock price today per share is 24.44 USD.
How to purchase Arcutis Biotherapeutics stock?
You can buy ARQT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arcutis Biotherapeutics?
The stock symbol or ticker of Arcutis Biotherapeutics is ARQT.
Which industry does the Arcutis Biotherapeutics company belong to?
The Arcutis Biotherapeutics industry is Biotechnology.
How many shares does Arcutis Biotherapeutics have in circulation?
The max supply of Arcutis Biotherapeutics shares is 125.69M.
What is Arcutis Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Arcutis Biotherapeutics PE Ratio is 111.09091000 now.
What was Arcutis Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Arcutis Biotherapeutics EPS is 0.22 USD over the trailing 12 months.
Which sector does the Arcutis Biotherapeutics company belong to?
The Arcutis Biotherapeutics sector is Healthcare.
Arcutis Biotherapeutics ARQT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26395.9 USD — |
+1.61
|
6.37B USD — | 26289.94 USD — | 26419.38 USD — | — - | 6.37B USD — |
|
US Tech Health Care
IXHC
US
|
1317.12 USD — |
+1.41
|
— — | 1313.4 USD — | 1322.92 USD — | — - | — — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3071.65 USD — |
+1.01
|
— — | 3069.92 USD — | 3084.34 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12970.14 USD — |
+1.59
|
— — | 12918.48 USD — | 12982.73 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7017.57 USD — |
+1.65
|
— — | 7002.07 USD — | 7074.78 USD — | — - | — — |
- {{ link.label }} {{link}}
